81 Biggest Movers From Yesterday

Gainers

• India Globalization Capital, Inc. (NYSE:IGC) shares surged 300.4% to close at $2.56 on Wednesday said the FDA notified on July 30 that it has authorized the company to initiate a Phase 1 human trial study for its investigational cannabinoid formulation for the treatment of patients suffering from mild to severe dementia due to Alzheimer's disease.
• Biofrontera AG (NASDAQ:BFRA) shares gained 50.1% to close at $30.50 after climbing over 53% on Tuesday. On Monday, Biofrontera disclosed subscription price for 1.00 % qualified subordinated mandatory convertible bond 2020/2021.
• The Pennant Group, Inc. (NASDAQ:PNTG) shares gained 40.7% to close at $36.77 after reporting better-than-expected Q2 results.
• Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) shares gained 35% to close at $19.27 after the company said it has signed a definitive merger agreement to be acquired by a consortium consisting of the company's management, led by CEO Bizuo Liu, which collectively holds about 51.5% of outstanding shares, and private equity investors, for $19.75 in cash for each outstanding share of common stock.
• Xpel Inc (NASDAQ:XPEL) surged 32.9% to close at $27.46 after the company reported better-than-expected Q3 results.
• EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) rose 30.3% to close at $5.38 after the company announced it has received positive feedback following its pre-IND meeting with the FDA and has been provided a path forward for the development of MoxiGel, a combination product for the treatment of bacterial conjunctivitis.
• Aemetis, Inc. (NASDAQ:AMTX) gained 28% to close at $3.34. Aemetis shares jumped 17% on Tuesday after the company highlighted the launch of Aemetis health products subsidiary.
• Summer Infant, Inc. (NASDAQ:SUMR) rose 27.5% to close at $17.83 after the company swung to a profit during the second quarter.
• Boxlight Corporation (NASDAQ:BOXL) gained 23.9% to close at $2.49 after the company announced a strategic partnership with Samsung for the US education market.
• Lincoln Educational Services Corporation (NASDAQ:LINC) rose 23.6% to close at $6.70. Lincoln Educational reported mixed quarterly results on Tuesday.
• Pacific Biosciences of California, Inc. (NASDAQ:PACB) climbed 23.5% to close at $5.52 after the company priced its 19 million share public offering of common stock at $4.47 per share.
• Alpha and Omega Semiconductor Limited (NASDAQ:AOSL) shares rose 21.4% to close at $13.89 following stronger-than-expected Q4 results.
• UP Fintech Holding Limited (NASDAQ:TIGR) gained 21.3% to close at $6.88. UP Fintech is expected to release Q2 earnings on August 18.
• Annexon, Inc. (NASDAQ:ANNX) surged 19.6% to close at $28.63.
• Crown Crafts, Inc. (NASDAQ:CRWS) rose 17.9% to close at $5.79 after the company reported better-than-expected Q1 results.
• Seres Therapeutics, Inc. (NASDAQ:MCRB) gained 17.6% to close at $23.56. On Monday, Seres announced positive topline results from apivotal Phase 3 study, dubbed ECOSPOR III, that is evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection.
• Penn Virginia Corporation (NASDAQ:PVAC) rose 17.4% to close at $14.56 as oil prices gained following a draw in US crude inventories as well as vaccine optimism after Trump announced the US will purchase 100 million doses of Moderna's coronavirus vaccine.
• Cornerstone Building Brands Inc (NYSE:CNR) climbed 17.1% to close at $8.57 after the company reported better-than-expected Q2 sales.
• Pacific Ethanol, Inc. (NASDAQ:PEIX) gained 16% to close at $4.06 after the company reported better-than-expected Q2 results.
• Synchronoss Technologies, Inc. (NASDAQ:SNCR) surged 15.6% to close at $4.14. Synchronoss Technologies, on Monday, reported better-than-expected Q2 results and also announced a contract renewal with Verizon to provide its white-label personal cloud platform.
• U.S. Gold Corp. (NASDAQ:USAU) shares rose 15.5% to close at $11.01 after the company reported that it has closed the acquisition of Northern Panther Resource Corporation.
• Cassava Sciences, Inc. (NASDAQ:SAVA) gained 15.1% to close at $3.36 after reporting a narrower Q2 loss.
• Brinker International, Inc. (NYSE:EAT) shares jumped 14.5% to close at $34.54 after reporting a narrower-than-expected quarterly loss.
• Horizon Global Corporation (NYSE:HZN) gained 14.3% to close at $6.40 after jumping 22% on Tuesday. Horizon Global posted a Q2 loss of $0.64 per share last week.
• TESSCO Technologies Incorporated (NASDAQ:TESS) jumped 14.1% to close at $8.32.
• Blink Charging Co. (NASDAQ:BLNK) shares gained 13.8% to close at $11.46. Blink Charging highlighted changes to membership program in conjunction with improved network, user experience and redesigned website.
• Nurix Therapeutics, Inc. (NASDAQ:NRIX) rose 13.6% to close at $18.23. Nurix Therapeutics, last month, priced its 11 million share IPO at $19 per share.
• Trevi Therapeutics, Inc. (NASDAQ:TRVI) climbed 13.4% to close at $6.60 after climbing 20% on Tuesday. Trevi Therapeutics is expected to report Q2 results on August 13.
• Tesla Inc (NASDAQ:TSLA) jumped 13.1% to close at $1,554.76 after reporting a 5-for-1 stock split, effective August 31, 2020.
• Commercial Vehicle Group, Inc. (NASDAQ:CVGI) rose 12.5% to close at $4.41. Commercial Vehicle reported upbeat quarterly results on Monday.
• AzurRx BioPharma, Inc. (NASDAQ:AZRX) shares climbed 11.8% to close at $1.13 after reporting interim data from its first patient cohort in the Phase 2 clinical trial of its MS1819.
• Hudbay Minerals Inc. (NYSE:HBM) shares gained 11.4% to close at $3.82 following Q2 results.
• uCloudlink Group Inc. (NASDAQ:UCL) shares rose 10.8% to close at $14.49.
• Inari Medical, Inc. (NASDAQ:NARI) climbed 10.6% to close at $68.72 after reporting stronger-than-expected Q2 results.
• LightInTheBox Holding Co., Ltd. (NYSE:LITB) rose 10.4% to close at $2.65 after dipping 27% on Tuesday.
• Daseke, Inc. (NASDAQ:DSKE) shares rose 9% to close at $6.88.
• DarioHealth Corp. (NASDAQ:DRIO) rose 8.2% to close at $14.70 following better-than-expected Q2 results.
• XpresSpa Group, Inc. (NASDAQ:XSPA) gained 8% to close at $3.64. On Tuesday, XpresSpa Reported that purported derivative suit filed in June 2019 by Moreton Binn and Marisol Binn against the company has been dismissed.
• eGain Corporation (NASDAQ:EGAN) rose 7.7% to close at $11.34. eGain reported preliminary results for the fourth quarter.
• Biomerica, Inc. (NASDAQ:BMRA) rose 6.4% to close at $9.12 after the company reported notice of allowance for new U.S. patent application covering diagnostic guided therapy for irritable bowel syndrome.
• American Eagle Outfitters Inc (NYSE:AEO) rose 5.6% to close at $12.21 after JP Morgan upgraded the company's stock from Neutral to Overweight.

Check out these big penny stock gainers and losers

Losers

• OneSpan Inc. (NASDAQ:OSPN) shares dropped 39.6% to close at $18.84 on Wednesday after the company reported weaker-than-expected Q2 results. Needham lowered the price target on the stock from $31 to $29.
• Kingold Jewelry, Inc. (NASDAQ:KGJI) dropped 31.9% to close at $0.4080 after the company reported voluntary delisting from the NASDAQ Capital Market, effective August 21.
• Staffing 360 Solutions Inc (NASDAQ:STAF) shares fell 27.9% to close at $0.75 after the company reported Q2 earnings, noting that they were negatively impacted by the economic downturn resulting from the Covid-19 pandemic.
• Super League Gaming, Inc. (NASDAQ:SLGG) dropped 24.3% to close at $2.43 after the company reported a loss for the second quarter.
• ThermoGenesis Holdings, Inc. (NASDAQ:THMO) dropped 19.8% to close at $4.53. ThermoGenesis said it will delay Q2 earnings release until Friday August 14, 2020.
• VirTra, Inc. (NASDAQ:VTSI) fell 19.8% to close at $3.5750 following Q2 results. VirTra posted a Q2 loss of $0.08 per share on sales of $2.77 million.
• Jumia Technologies AG (NYSE:JMIA) fell 19.7% to close at $13.15 after the company reported its Q2 earnings results and reached an agreement to resolve class action lawsuits filed in the US District Court And New York County Supreme Court.
• Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) shares declined 19.3% to close at $4.10.
• Novavax, Inc. (NASDAQ:NVAX) fell 16.8% to close at $124.42 with as investors weighing competitive concerns as other coronavirus vaccine makers see continued progress.
• Kubient Inc (NASDAQ:KBNT) declined 16.8% to close at $4.15. Kubient priced its upsized 2.5 million unit IPO at $5 per unit.
• Edesa Biotech, Inc. (NASDAQ:EDSA) fell 16.8% to close at $6.81 after reporting Q3 results.
• HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) fell 16.7% to close at $0.5431 following wider-than-expected quarterly loss.
• Trevena, Inc. (NASDAQ:TRVN) fell 16.4% to close at $2.29 after the company reported a proposed common stock offering.
• Aethlon Medical, Inc. (NASDAQ:AEMD) fell 15.9% to close at $1.59 after the company posted Q1 results.
• Co-Diagnostics, Inc. (NASDAQ:CODX) fell 15.8% to close at $19.57. Co-Diagnostics is projected to report Q2 earnings on August 13.
• Intellicheck Inc (NYSE:IDN) dropped 15.7% to close at $7.04 after the company reported Q2 earnings results.
• Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) fell 15.4% to close at $0.9645 after declining over 7% on Tuesday.
• Landec Corporation (NASDAQ:LNDC) shares declined 15.2% to close at $9.16 following Q4 results.
• T2 Biosystems, Inc. (NASDAQ:TTOO) dipped 15% to close at $1.59 after the company reported a Q2 loss of $0.09 per share.
• Super Micro Computer, Inc. (NASDAQ:SMCI) dropped 14.7% to close at $ 26.01 following Q4 results.
• Vaxart, Inc. (NASDAQ:VXRT) fell 14.4% to close at $9.20. HC Wainwright & Co. maintained Vaxart with a Buy rating and raised the price target from $7 to $17. Vaxart, on Monday, filed for an investigational new drug application for a coronavirus vaccine.
• Veritone, Inc. (NASDAQ:VERI) shares dropped 14.2% to close at $10.35. Veritone reported upbeat Q2 results on Monday.
• SCWorx Corp. (NASDAQ:WORX) tumbled 14.1% to close at $2.07 after dropping 22% on Tuesday.
• Kelly Services, Inc. (NASDAQ:KELYB) shares declined 14% to close at $32.85. Kelly Services released quarterly earnings last week.
• Omeros Corporation (NASDAQ:OMER) dropped 14% to close at $13.67 after the company priced its concurrent underwritten public offerings of 6.9 million of shares of common stock at a public offering price of $14.50 per share.
• The LGL Group, Inc. (NYSE:LGL) fell 13.8% to close at $8.56 after the company reported lower earnings and sales for the second quarter.
• Fulcrum Therapeutics, Inc. (NASDAQ:FULC) dipped 12.7% to close at $7.77. Morgan Stanley and B of A Securities downgraded Fulcrum Therapeutics.
• Triumph Group, Inc. (NYSE:TGI) fell 12.3% to close at $7.43 after JP Morgan downgraded the stock from Neutral to Underweight and lowered its price target from $10 to $8 per share.
• Tarena International, Inc. (NASDAQ:TEDU) shares dropped 12.3% to close at $1.78 after reporting H1 results.
• Red Robin Gourmet Burgers, Inc. (NASDAQ:RRGB) slipped 12.1% to close at $9.58 after reporting downbeat quarterly results.
• Sorrento Therapeutics, Inc. (NASDAQ:SRNE) dropped 11.9% to close at $12.41 after dropping 25% on Tuesday.
• Capricor Therapeutics, Inc. (NASDAQ:CAPR) fell 11.6% to close at $5.94.
• Synacor Inc (NASDAQ:SYNC) fell 11.3% to close at $1.18 after the company reported worse-than-expected Q2 sales.
• Personalis Inc (NASDAQ:PSNL) fell 10.4% to close at $19.01 after the company priced its 6.5 million share public offering of common stock at $19 per share.
• ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) shares fell 10.3% to close at $3.04. ZIOPHARM Oncology, last week, reported a Q2 loss of $0.09 per share.
• Braemar Hotels & Resorts, Inc. (NYSE:BHR) fell 8.5% to close at $2.80.
• Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) fell 8.3% to close at $0.3009 after reporting a Q2 loss of $0.06 per share.
• Plug Power Inc. (NASDAQ:PLUG) fell 6% to close at $10.63 after the company announced it is commencing a registered public offering of $300 million of its common stock.
• Immutep Limited (NASDAQ:IMMP) fell 4.4% to close at $1.31. On Tuesday, Immutep announced it has been granted a US Patent for Eftilagimod Alpha in Chemo-immunotherapy combination.
• K12 Inc. (NYSE:LRN) fell 4.3% to close at $45.05 despite the company reported better-than-expected Q4 results.